3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase 1
3
Phase 1/2
2
Phase 3
1
Phase 2/3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
42
Genitourinary
36
Gastrointestinal
34
Other hematologic neoplasm
32
Breast
32
Lymphoid
31
Gynecologic
18
Plasma cell
15
Classical hematology
11
Dermatologic
10
Myeloid
7
Endocrine
5
Sarcoma
4
Head & Neck
4
CNS
3
Tumor-Agnostic
2
NET
2
Other solid neoplasm
1
Conditions
Mesothelioma
1
Interventions
Pemetrexed
1
Nivolumab
1
Ipilimumab
1
Cisplatin
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Has announcements
×
Other solid neoplasm
×
Clear all
NCT02899299
2024-05-21
CheckMate743
Bristol-Myers Squibb
Phase 3
Completed
605 enrolled
17 charts
1 FDA